The Texas Heart Institute reports its experience with 27 patients with prior continuous flow LVADs who had undergone varying degrees of device explantation. Although the numbers are small, the explantation methods ranged from near-complete device removal to driveline transection and removal.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Mechanical Circulatory Assistance
Surgical approach to continuous-flow left ventricular assist device explantation: A comparison of outcomes
August 14, 2015
Effect of Preoperative Albumin Levels on Outcomes in Patients Undergoing Left Ventricular Device Implantation.
August 12, 2015
A single institution retrospectively reviewed the correlation of preoperative serum albumin level with outcomes after LVAD implantation from 2006 to 2014. A lower albumin level was associated with a significant increase in postop renal failure and prolonged hospitalization, but not overall short-term and long-term survival.
Preoperative predictors and outcomes of right ventricular assist device implantation following continuous-flow left ventricular assist device implantation
August 6, 2015
This retrospective analysis of the BTT continuous flow (CF) LVAD experience from Harefield Hospital addresses the question: "What are the predictors of the requirement for an RVAD at the time of LVAD implantation?" Of the 152 patients included in the study, 23% underwent RVAD implantation.
Novel Application of a Percutaneous Left Ventricular Assist Device as a Bridge to Transplant in a Pediatric Patient with Severe Heart Failure Due to Viral Myocarditis
June 30, 2015
In this video, the authors describe their experience using a percutaneous left ventricular assist device (LVAD) as a bridge to transplant in a morbidly obese pediatric patient with severe heart failure due to viral myocarditis.
Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis
June 20, 2015
The University of Wisconsin group analyzed the etiology, costs, and effect on survival of unplanned readmissions after LVAD surgery. At a median follow-up of 11 months, 68 of the 103 patients (66%) were readmitted. The top 3 causes of readmission were GI bleeding, driveline infection, and stroke.
Extracorporeal Membrane Oxygenation Support in Postcardiotomy Elderly Patients: The Mayo Clinic Experience
April 19, 2015
The Mayo Clinic reviewed its series using VA ECMO for postcardiotomy support in patients older than the age of 70 years. Not surprisingly, only a quarter of patients were able to be discharged alive.
April 19, 2015
The authors retrospectively analyzed the causes of death and their temporal relationship to surgery for close to 500 patients undergoing LVAD implantation at their institutions.
April 14, 2015
Filmed at the 2015 STS Annual Meeting in San Diego, Michael Bolanos and Mark Slaughter discuss topics in mechanical circulatory support and heart transplantation.
2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care
April 9, 2015
This concensus statement reviews the unique physiology, insertion techniques, and clinical indications for use of percutaneous mechanical circulatory support devices. As the options for management of different etiologies of heart failure in adult and pediatric populations expand, understanding the advantages of specific devices is vital.
Extracorporeal life support in cardiogenic shock: impact of acute versus chronic etiology on outcome
March 2, 2015
The authors retrospectively analyze outcomes for patients placed on ECMO for cardiogenic shock, and separately analyze the patients depending on whether the ECMO support was for isolated acute cardiogenic shock or for acute-upon-chronic cardiogenic shock.